MS SB2694 | 2026 | Regular Session
Status
Completed Legislative Action
Sponsorship: Bipartisan Bill
Status: Failed on March 3 2026 - 100% progression
Action: 2026-03-03 - Died In Committee
Text: Latest bill text (Engrossed) [HTML]
Sponsorship: Bipartisan Bill
Status: Failed on March 3 2026 - 100% progression
Action: 2026-03-03 - Died In Committee
Text: Latest bill text (Engrossed) [HTML]
Summary
An Act To Require Each Health Benefit Plan, Contract Or Agreement That Is Entered Into Or Renewed On Or After July 1, 2026, To Offer Coverage For Biomarker Testing For The Purposes Of Diagnosis, Treatment, Appropriate Management, Or Ongoing Monitoring Of An Enrollee's Disease Or Condition When The Test Is Supported By Medical And Scientific Evidence; To Require An Insurer To Provide Specific Written Justification For Any Denied Claim For Coverage Of Testing That Is Supported By Such Evidence; To Authorize The Department Of Insurance To Conduct Periodic Audits And Reviews To Ensure Compliance With This Act; To Define "biomarker Testing" And Other Terms Used In This Act; To Amend Sections 43-13-117 And 83-5-907, Mississippi Code Of 1972, To Conform To The Preceding Provisions; And For Related Purposes.
Title
Health insurance; require coverage for biomarker testing for certain purposes when supported by medical and scientific evidence.
Sponsors
Roll Calls
2026-02-11 - Senate - Senate Passed (Y: 52 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2026-03-03 | House | Died In Committee |
| 2026-02-16 | House | Referred To Public Health and Human Services;Insurance |
| 2026-02-12 | Senate | Transmitted To House |
| 2026-02-11 | Senate | Passed |
| 2026-02-03 | Senate | Title Suff Do Pass |
| 2026-02-03 | Senate | DR - TSDP: IN To AP |
| 2026-01-19 | Senate | Referred To Insurance;Appropriations |
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| 43 | 13 | 117 | Amended Code | See Bill Text |
| 83 | 5 | 907 | Amended Code | See Bill Text |
